Literature DB >> 15357652

Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections.

C Hézode1, F Roudot-Thoraval, E-S Zafrani, D Dhumeaux, J-M Pawlotsky.   

Abstract

This study reports evidence that hepatocellular steatosis, a frequent histological feature of chronic hepatitis C, is principally metabolic in hepatitis C virus (HCV) genotype 1-infected patients, whereas it is principally virus-induced in HCV genotype 3-infected patients. Multivariate analysis of data on 176 patients with chronic hepatitis C revealed that the severity of steatosis was independently related to HCV RNA load alone in patients infected by HCV genotype 3, whereas it was independently related to the body mass index, daily alcohol intake and histological activity grade (but not viral load) in patients infected by HCV genotype 1. These findings suggest that steatosis is a cytopathic lesion induced by HCV genotype 3, whereas HCV genotype 1 is not steatogenic per se or at the usual in vivo expression levels.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15357652     DOI: 10.1111/j.1365-2893.2004.00528.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  22 in total

Review 1.  Genotype 3 Infection: The Last Stand of Hepatitis C Virus.

Authors:  Austin Chan; Keyur Patel; Susanna Naggie
Journal:  Drugs       Date:  2017-02       Impact factor: 9.546

Review 2.  Adiponectin serum level in chronic hepatitis C infection and therapeutic profile.

Authors:  Valentina Peta; Carlo Torti; Natasa Milic; Alfredo Focà; Ludovico Abenavoli
Journal:  World J Hepatol       Date:  2015-01-27

Review 3.  Hepatitis C virus induced insulin resistance impairs response to anti viral therapy.

Authors:  Abdel-Rahman El-Zayadi; Mahmoud Anis
Journal:  World J Gastroenterol       Date:  2012-01-21       Impact factor: 5.742

4.  Hepatitis C virus infection and nonalcoholic steatohepatitis.

Authors:  Anish Patel; Stephen A Harrison
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-05

5.  Peginterferon vs. interferon in the treatment of different HCV genotype infections in HIV patients.

Authors:  S Zhao; D Cheng; E Liu; H Yu; H Yang; X Xue; Y Chu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-06-17       Impact factor: 3.267

6.  Hepatic steatosis in hepatitis C is a storage disease due to HCV interaction with microsomal triglyceride transfer protein (MTP).

Authors:  Silvia Mirandola; David Bowman; Mahmood M Hussain; Alfredo Alberti
Journal:  Nutr Metab (Lond)       Date:  2010-02-23       Impact factor: 4.169

7.  Inhibition of core gene of HCV 3a genotype using synthetic and vector derived siRNAs.

Authors:  Saba Khaliq; Shah Jahan; Bushra Ijaz; Waqar Ahmad; Sultan Asad; Asim Pervaiz; Baila Samreen; Mahwish Khan; Sajida Hassan
Journal:  Virol J       Date:  2010-11-13       Impact factor: 4.099

8.  Specific polymorphisms in hepatitis C virus genotype 3 core protein associated with intracellular lipid accumulation.

Authors:  Ravi Jhaveri; John McHutchison; Keyur Patel; Guan Qiang; Anna Mae Diehl
Journal:  J Infect Dis       Date:  2008-01-15       Impact factor: 5.226

9.  The prevalence of bright liver echo pattern in patients with chronic hepatitis C: correlation with steatosis and fibrosis.

Authors:  Maurizio Loy; Giancarlo Serra; Luchino Chessa
Journal:  J Ultrasound       Date:  2014-07-05

Review 10.  Metabolic alterations and hepatitis C: From bench to bedside.

Authors:  Ming-Ling Chang
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.